Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Just a typical Drop

<< Previous

Bullboard Posts

Next >>

Post by RoboticSlaveon Apr 09, 2021 3:57pm

449 Views

Post# 32968446

Just a typical Drop

Oncolytics is a stock that likes to be played with, get it up to $5-$6 and then tank it back to $3.50, not bad if you play your cards right, but eventually it will get to $5-$6 and then skyrocket up, but I sold some mid-$5 and kept some, don't wanna miss out when the rocket does actually launch

<< Previous

Bullboard Posts

Next >>

Corus reports Q1 profit drop in the face of falling revenue